Your browser doesn't support javascript.
loading
Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccines.
Liu, Yi; Sánchez-Ovando, Stephany; Carolan, Louise; Dowson, Leslie; Khvorov, Arseniy; Jessica Hadiprodjo, A; Tseng, Yeu Yang; Delahunty, Catherine; Khatami, Ameneh; Macnish, Marion; Dougherty, Sonia; Hagenauer, Michelle; Riley, Kathryn E; Jadhav, Ajay; Harvey, Joanne; Kaiser, Marti; Mathew, Suja; Hodgson, David; Leung, Vivian; Subbarao, Kanta; Cheng, Allen C; Macartney, Kristine; Koirala, Archana; Marshall, Helen; Clark, Julia; Blyth, Christopher C; Wark, Peter; Kucharski, Adam J; Sullivan, Sheena G; Fox, Annette.
Afiliação
  • Liu Y; Department of Infectious Diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourn
  • Sánchez-Ovando S; Department of Infectious Diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourn
  • Carolan L; WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Dowson L; Department of Infectious Diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Khvorov A; Department of Infectious Diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourn
  • Jessica Hadiprodjo A; Department of Infectious Diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourn
  • Tseng YY; Department of Infectious Diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourn
  • Delahunty C; Immune Health Program, Hunter Medical Research Institute and School of Medicine and Public Health, University of Newcastle, Newcastle, Australia.
  • Khatami A; The Children's Hospital at Westmead, Sydney Children's Hospital Network, National Centre for Immunisation Research and Surveillance, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia.
  • Macnish M; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Australia.
  • Dougherty S; Queensland Children's Hospital, Children's Health Queensland Hospital and Health Service, and University of Queensland, Brisbane, Australia.
  • Hagenauer M; Alfred Health, Monash Health and Monash University, Melbourne, Australia.
  • Riley KE; Adelaide Medical School and Robinson Research Institute, The University of Adelaide, Adelaide, Australia; Division of Paediatric Medicine, Women's and Children's Health Network, Adelaide, Australia.
  • Jadhav A; The Children's Hospital at Westmead, Sydney Children's Hospital Network, National Centre for Immunisation Research and Surveillance, Sydney, Australia.
  • Harvey J; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Australia.
  • Kaiser M; Alfred Health, Monash Health and Monash University, Melbourne, Australia.
  • Mathew S; Adelaide Medical School and Robinson Research Institute, The University of Adelaide, Adelaide, Australia; Division of Paediatric Medicine, Women's and Children's Health Network, Adelaide, Australia.
  • Hodgson D; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
  • Leung V; Department of Infectious Diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Subbarao K; Department of Infectious Diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Cheng AC; Alfred Health, Monash Health and Monash University, Melbourne, Australia.
  • Macartney K; The Children's Hospital at Westmead, Sydney Children's Hospital Network, National Centre for Immunisation Research and Surveillance, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia.
  • Koirala A; The Children's Hospital at Westmead, Sydney Children's Hospital Network, National Centre for Immunisation Research and Surveillance, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia.
  • Marshall H; Adelaide Medical School and Robinson Research Institute, The University of Adelaide, Adelaide, Australia; Division of Paediatric Medicine, Women's and Children's Health Network, Adelaide, Australia.
  • Clark J; Queensland Children's Hospital, Children's Health Queensland Hospital and Health Service, and University of Queensland, Brisbane, Australia.
  • Blyth CC; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Australia; School of Medicine, University of Western Australia, Perth Children's Hospital, and Department of Microbiology, PathWest Laboratory Medicine, QEII medical centre, Perth, Australia.
  • Wark P; Immune Health Program, Hunter Medical Research Institute and School of Medicine and Public Health, University of Newcastle, Newcastle, Australia.
  • Kucharski AJ; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
  • Sullivan SG; Department of Infectious Diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourn
  • Fox A; Department of Infectious Diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourn
Vaccine ; 41(48): 7192-7200, 2023 11 22.
Article em En | MEDLINE | ID: mdl-37903679

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / COVID-19 Limite: Humans Idioma: En Revista: Vaccine Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / COVID-19 Limite: Humans Idioma: En Revista: Vaccine Ano de publicação: 2023 Tipo de documento: Article